Primary prophylaxis against variceal bleeding: β-Blockers, endoscopic ligation, or both?

Naga Chalasani, Thomas D Boyer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Variceal bleeding is one of the complications of cirrhosis that leads to significant morbidity and mortality. It is recommended that all patients with cirrhosis be screened for gastroesophageal varices and those with large varices should be offered primary prophylaxis. Nonselective beta-blockers (nadolol or propranolol) are the treatment of choice for primary prophylaxis but there are a number of limitations to their use. A number of studies have evaluated the efficacy of variceal band ligation (VBL) in providing primary prophylaxis, either in comparison to no treatment or to beta-blockers. VBL is very effective in preventing the initial bleed when compared to no treatment, but it is not superior to beta-blockers. In this issue of the journal the effect of beta-blockers on bleeding in patients undergoing VBL is examined and no benefit compared to VBL alone is shown. Thus, patients with large varices should be treated with beta-blockers and VBL should be offered to those cirrhotics who are unable to take beta-blockers. Further study is required to determine if VBL in combination with beta-blockers is more effective than the beta-blockers alone.

Original languageEnglish (US)
Pages (from-to)805-807
Number of pages3
JournalAmerican Journal of Gastroenterology
Volume100
Issue number4
DOIs
StatePublished - Apr 2005

Fingerprint

Ligation
Hemorrhage
Varicose Veins
Fibrosis
Nadolol
Propranolol
Therapeutics
Morbidity
Mortality

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Primary prophylaxis against variceal bleeding : β-Blockers, endoscopic ligation, or both? / Chalasani, Naga; Boyer, Thomas D.

In: American Journal of Gastroenterology, Vol. 100, No. 4, 04.2005, p. 805-807.

Research output: Contribution to journalArticle

@article{7b7d098f8e1045afb989e99ae27e508a,
title = "Primary prophylaxis against variceal bleeding: β-Blockers, endoscopic ligation, or both?",
abstract = "Variceal bleeding is one of the complications of cirrhosis that leads to significant morbidity and mortality. It is recommended that all patients with cirrhosis be screened for gastroesophageal varices and those with large varices should be offered primary prophylaxis. Nonselective beta-blockers (nadolol or propranolol) are the treatment of choice for primary prophylaxis but there are a number of limitations to their use. A number of studies have evaluated the efficacy of variceal band ligation (VBL) in providing primary prophylaxis, either in comparison to no treatment or to beta-blockers. VBL is very effective in preventing the initial bleed when compared to no treatment, but it is not superior to beta-blockers. In this issue of the journal the effect of beta-blockers on bleeding in patients undergoing VBL is examined and no benefit compared to VBL alone is shown. Thus, patients with large varices should be treated with beta-blockers and VBL should be offered to those cirrhotics who are unable to take beta-blockers. Further study is required to determine if VBL in combination with beta-blockers is more effective than the beta-blockers alone.",
author = "Naga Chalasani and Boyer, {Thomas D}",
year = "2005",
month = "4",
doi = "10.1111/j.1572-0241.2005.41855.x",
language = "English (US)",
volume = "100",
pages = "805--807",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Primary prophylaxis against variceal bleeding

T2 - β-Blockers, endoscopic ligation, or both?

AU - Chalasani, Naga

AU - Boyer, Thomas D

PY - 2005/4

Y1 - 2005/4

N2 - Variceal bleeding is one of the complications of cirrhosis that leads to significant morbidity and mortality. It is recommended that all patients with cirrhosis be screened for gastroesophageal varices and those with large varices should be offered primary prophylaxis. Nonselective beta-blockers (nadolol or propranolol) are the treatment of choice for primary prophylaxis but there are a number of limitations to their use. A number of studies have evaluated the efficacy of variceal band ligation (VBL) in providing primary prophylaxis, either in comparison to no treatment or to beta-blockers. VBL is very effective in preventing the initial bleed when compared to no treatment, but it is not superior to beta-blockers. In this issue of the journal the effect of beta-blockers on bleeding in patients undergoing VBL is examined and no benefit compared to VBL alone is shown. Thus, patients with large varices should be treated with beta-blockers and VBL should be offered to those cirrhotics who are unable to take beta-blockers. Further study is required to determine if VBL in combination with beta-blockers is more effective than the beta-blockers alone.

AB - Variceal bleeding is one of the complications of cirrhosis that leads to significant morbidity and mortality. It is recommended that all patients with cirrhosis be screened for gastroesophageal varices and those with large varices should be offered primary prophylaxis. Nonselective beta-blockers (nadolol or propranolol) are the treatment of choice for primary prophylaxis but there are a number of limitations to their use. A number of studies have evaluated the efficacy of variceal band ligation (VBL) in providing primary prophylaxis, either in comparison to no treatment or to beta-blockers. VBL is very effective in preventing the initial bleed when compared to no treatment, but it is not superior to beta-blockers. In this issue of the journal the effect of beta-blockers on bleeding in patients undergoing VBL is examined and no benefit compared to VBL alone is shown. Thus, patients with large varices should be treated with beta-blockers and VBL should be offered to those cirrhotics who are unable to take beta-blockers. Further study is required to determine if VBL in combination with beta-blockers is more effective than the beta-blockers alone.

UR - http://www.scopus.com/inward/record.url?scp=17544373930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17544373930&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2005.41855.x

DO - 10.1111/j.1572-0241.2005.41855.x

M3 - Article

C2 - 15784022

AN - SCOPUS:17544373930

VL - 100

SP - 805

EP - 807

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 4

ER -